These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7363715

  • 41. [Efficacy and tolerability of cefuroxime-axetil in infections of the upper respiratory tract. Comparative study with cefadroxil].
    Dupuis G, Ebbo D, Evennou A, Pappo M.
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(1):123-6. PubMed ID: 2491707
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Cefuroxime axetil. An antibiotic advances].
    Fortschr Med Suppl; 1990; 92():4-13. PubMed ID: 2199359
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract.
    Geckler RW.
    Clin Ther; 1994; 16(4):662-72. PubMed ID: 7982254
    [Abstract] [Full Text] [Related]

  • 48. [One year of Zinnat: effective antibiosis and good tolerance].
    Knothe H.
    Fortschr Med Suppl; 1990; 92():13-5. PubMed ID: 2379907
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
    Pines A, Jabbar MA, Khorasani MH, Raafat H, Sharma JC.
    Chemotherapy; 1981; 27(1):68-72. PubMed ID: 7215006
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Laboratory and clinical evaluations of cefuroxime in pediatrics (author's transl)].
    Hori M, Kono S, Hashimoto F, Toyonaga Y, Kurosu Y, Matsunaga T, Takahashi T.
    Jpn J Antibiot; 1979 Nov; 32(11):1137-45. PubMed ID: 513296
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [The French experience with moxalactam in pneumology].
    Leng B, Imbert Y, Coomans D.
    Sem Hop; 1983 Jun 30; 59(26):1977-80. PubMed ID: 6310790
    [Abstract] [Full Text] [Related]

  • 56. [Evaluation of T-2588 in the treatment of respiratory tract infection].
    Shimokata K, Suetsugu S, Umeda H, Inada S, Torikai K, Morishita M, Wada M, Yamamoto M, Yamori S, Kishimoto H.
    Jpn J Antibiot; 1986 Nov 30; 39(11):2897-913. PubMed ID: 3820569
    [Abstract] [Full Text] [Related]

  • 57. Cephalexin in lower respiratory infections.
    Practitioner; 1972 Mar 30; 208(245):421-3. PubMed ID: 4554484
    [No Abstract] [Full Text] [Related]

  • 58. [Fundamental and clinical studies of cefuroxime, a new cephalosporin antibiotic, in pediatric field (author's transl)].
    Hirama Y, Iwasaki A, Suzuki H, Nakazawa S, Narita A, Niino K, Satoh H, Nakazawa S, Chikaoka H, Oka S.
    Jpn J Antibiot; 1979 Nov 30; 32(11):1146-60. PubMed ID: 513297
    [Abstract] [Full Text] [Related]

  • 59. [Clinical results of cefuroxime (CXM) therapy in pediatric infections (author's transl)].
    Nakamura Y, Yanagisawa K, Ichihashi H.
    Jpn J Antibiot; 1979 Nov 30; 32(11):1132-6. PubMed ID: 390177
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.